HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

High incidence of meropenem resistance among alpha-hemolytic streptococci in children with cancer.

AbstractBACKGROUND:
Infections caused by antibiotics-resistant Gram-positive bacteria have been reported from many pediatric hematology-oncology centers.
METHODS:
The susceptibility profiles to meropenem, piperacillin, and vancomycin among oral flora isolates of alpha-hemolytic streptococci (AHS) obtained from six children with cancer who received several empirical therapies (ET) against febrile neutropenia, were investigated.
RESULTS:
Meropenem minimum inhibitory concentration (MIC) of AHS isolated from ET patients was 2.167 +/- 0.258 microg/mL (mean +/- SD), which was significantly higher than the MIC of AHS isolated from control groups. Intriguingly, AHS isolated approximately 6 months after hospital discharge indicated recovery of susceptibility to meropenem.
CONCLUSIONS:
AHS isolates from neutropenic children with cancer should be checked for antibiotic susceptibility, even against carbapenems.
AuthorsMasako Abe, Takehiko Kamijo, Shigeyuki Matsuzawa, Jun Miki, Yozo Nakazawa, Kazuo Sakashita, Tadashi Okabe, Takayuki Honda, Jun-ichi Mitsuyama, Kenichi Koike
JournalPediatrics international : official journal of the Japan Pediatric Society (Pediatr Int) Vol. 51 Issue 1 Pg. 103-6 (Feb 2009) ISSN: 1442-200X [Electronic] Australia
PMID19371287 (Publication Type: Journal Article)
Chemical References
  • Anti-Bacterial Agents
  • Thienamycins
  • Meropenem
Topics
  • Adolescent
  • Anti-Bacterial Agents (pharmacology)
  • Child
  • Child, Preschool
  • Drug Resistance, Multiple, Bacterial
  • Humans
  • Infant
  • Infant, Newborn
  • Meropenem
  • Neoplasms (complications)
  • Neutropenia (complications, microbiology)
  • Streptococcal Infections (complications, microbiology)
  • Streptococcus (drug effects, isolation & purification)
  • Thienamycins (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: